Literature DB >> 1500675

Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy.

C C van der Rijt1, S W Schalm.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1500675     DOI： 10.1016/0168-8278(92)90148-i

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

Review 1.  Psychiatric aspects of portal-systemic encephalopathy.

Authors:  J Wiltfang; W Nolte; K Weissenborn; J Kornhuber; E Rüther
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  Neurophysiological investigation of hepatic encephalopathy.

Authors:  Piero Amodio; Angelo Gatta
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

4.  Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG.

Authors:  P Amodio; J C Quero; F Del Piccolo; A Gatta; S W Schalm
Journal:  Metab Brain Dis       Date:  1996-12       Impact factor: 3.584

Review 5.  Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach.

Authors:  Sara Montagnese; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Actigraphy: A new diagnostic tool for hepatic encephalopathy.

Authors:  Isabelle Hourmand-Ollivier; Marie-Astrid Piquet; Jean Pierre Toudic; Pierre Denise; Thông Dao
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

7.  Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.

Authors:  H P Meyer; D A Legemate; W van den Brom; J Rothuizen
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

8.  Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy.

Authors:  P Amodio; P Marchetti; F Del Piccolo; C Rizzo; R M Iemmolo; L Caregaro; G Gerunda; A Gatta
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

9.  Hepatic encephalopathy verified by psychometric testing and EEG in cirrhotic patients: effects of mesocaval interposition shunt or sclerotherapy.

Authors:  B Isaksson; L-H Thorell; F Bengtsson; I Rosén; B Jeppsson
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

10.  Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications.

Authors:  Regina Rodrigo; Pilar Monfort; Omar Cauli; Slaven Erceg; Vicente Felipo
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.